Whittier Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Whittier Trust’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-102,483	Closed	-$1.43M	–	1356
2017 Q4	$1.43M	Buy	102,483 +2,055	+2%	+$27.8K	0.05%	250
2017 Q3	$1.86M	Buy	100,428 +1,427	+1%	+$23.9K	0.07%	222
2017 Q2	$1.67M	Buy	99,001 +2,557	+3%	+$38.9K	0.06%	229
2017 Q1	$1.29M	Buy	96,444 +4,658	+5%	+$73K	0.05%	247
2016 Q4	$1.38M	Buy	91,786 +246	+0.3%	+$3.25K	0.06%	229
2016 Q3	$1.07M	Buy	91,540 +45,715	+100%	+$537K	0.05%	251
2016 Q2	$495K	Buy	45,825 +556	+1%	+$5.74K	0.02%	337
2016 Q1	$418K	Hold	45,269	–	–	0.02%	359
2015 Q4	$672K	Buy	45,269 +474	+1%	+$7.93K	0.03%	316
2015 Q3	$735K	Hold	44,795	–	–	0.04%	286
2015 Q2	$1.02M	Hold	44,795	–	–	0.05%	276
2015 Q1	$681K	Hold	44,795	–	–	0.03%	305
2014 Q4	$539K	Hold	44,795	–	–	0.03%	325
2014 Q3	$508K	Hold	44,795	–	–	0.02%	325
2014 Q2	$541K	Hold	44,795	–	–	0.03%	319
2014 Q1	$522K	Buy	+44,795	New	+$759K	0.03%	312

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Whittier Trust's MNTA Position: Q1 2018 in Review

Whittier Trust sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2018, closing a stake of 102,483 shares — an estimated $1.43M sold.

Whittier Trust first reported a position in MNTA in Q1 2014 and held it in 16 quarters. The position peaked at $1.86M in Q3 2017. 163 funds tracked by Wall St. Rank hold MNTA as of Q1 2018.

Whittier Trust reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Whittier Trust sold 102,483 Momenta Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.43M.
Whittier Trust first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 16 quarters.
Whittier Trust's Momenta Pharmaceuticals, Inc. position peaked at $1.86M in Q3 2017.
163 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2018.

Based on Whittier Trust's 13F filing for Q1 2018, filed 1 May 2018.